急性脑梗死动脉溶栓血管再通对急性期预后的影响

被引：12

作者：

陈颖

王志海

机构：

[1] 湛江中心人民医院

来源：

现代医院 | 2010年 / 10卷 / 12期

关键词：

急性脑梗死; 动脉溶栓; 血管再通; 预后;

D O I：

暂无

中图分类号：

R743.33 [脑栓塞];

学科分类号：

1002 ;

摘要：

目的研究经动脉溶栓治疗急性脑梗死患者,梗死相关血管再通对近期预后的影响。方法回顾性分析2007年9月～2010年9月在本院神经内科收治的急性脑梗死动脉溶栓患者58例。采用Gon-ner的血管再通分级标准判断血管再通,利用美国国立卫生研究院卒中量表评分(NIHSS),比较再通与未通组神经功能缺损情况。用MRS评价神经功能恢复状况。结果 58例中再通38例(65.5%),未通20例(34.5%)。溶栓治疗后血管再通组1 h NIHSS(19.00±3.54)较血管未通组(26.50±3.10)明显降低(p<0.05);溶栓治疗后30 d血管再通组NIHSS(12.25±3.15)明显低于血管未通组[(19.12±3.35),p<0.05]。治疗1～30 d,血管再通组NIHSS评分低于对照组(p<0.05)。血管再通组30 d预后良好为28例(73%),而血管未通组预后好良好为7例(35%)(p<0.05)。结论急性脑梗死动脉溶栓后血管再通对改善急性期预后起十分重要作用。

引用

页码：49 / 51

页数：3

共 7 条

[1]

Intra-arterial thrombolysis. AJNY . 2001

[2]

Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. The National Institute of Neurological Disorders and Stroke rt PA Stroke Study Group. New England Journal of Medicine, The . 1995

[3]

Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Higashida RT,Furlan AJ,Roberts H,et al. Stroke . 2003

[4]

Intraarterial thrombolysis for treatment of acute stroke: experience in 26 patients with long-term follow-up. Jahan R,Duckwiler GR,Kidwell CS,et al. American Journal of Neuroradiology . 1999

[5]

Intra-arterial prourokinase for acute ischemic stroke.The PROACT Ⅱ study. A randomized controlled trial: prolyse in acute cerebral thromboembolism. Furlan A,Higashida R,Wechsler L,et al. The Journal of The American Medical Association . 1999

[6]

PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. del Zoppo GJ,Higashida RT,Furlan AJ,et al. Stroke . 1998

[7]

Thrombolysisrelated hemorrhage infarctiom. MOLINA C A,ALVAROR S J,MONTANER Jet al. Stroke . 2002

← 1 →